Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Interleukin-2 3pazopanib 2lenvatinib 2aldesleukin 2Nivolumab 2Nephrectomy 2Metastasectomy 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Fluorodeoxyglucose F18 2Cryosurgery 2Biopsy 2tremelimumab 1spartalizumab 1pembrolizumab 1gallium 68 PSMA-11 1enzalutamide 1denileukin diftitox 1daratumumab 1clevudine 1canakinumab 1cabozantinib 1Sorafenib 1Microscopy, Electron 1Isoflavones 1Immunoglobulin G 1Genistein 1FS 069 1FAPI-46 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Renal Cell × Diet, Fat-Restricted × Clear all
NCT02729194 2019-06-10

Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Completed
16 enrolled 17 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡